The nuclear factor kappaB (NF-kB) family of transcription factors consists of 15 possible dimers whose activity is controlled by a family of inhibitor proteins, known as IkBs. A variety of cellular stimuli, many of them transduced by members of the tumor necrosis factor receptor (TNFR) superfamily, induce degradation of IkBs to activate an overlapping subset of NF-kB dimers. However, generation and stimulusresponsive activation of NF-kB dimers are intimately linked via various cross-regulatory mechanisms that allow crosstalk between different signaling pathways through the NF-kB signaling system. In this review, we summarize these mechanisms and discuss physiological and pathological consequences of crosstalk between apparently distinct inflammatory and developmental signals. We argue that a systems approach will be valuable for understanding questions of specificity and emergent properties of highly networked cellular signaling systems. #
1. Introduction
The TNF receptor superfamily
The tumor necrosis factor receptor (TNFR) superfamily comprises more than two dozen members. Their primary physiological functions appear to be in the immune system, both in the development of specialized immune cells and organs, and in the immune response to pathogens. Many TNFR superfamily members and their extracellular ligands have been shown to play critical roles in the organization of the spleen, the development of lymph nodes and thymus, and maturation of T-cells and B-cells within these organs. The lymphotoxin beta receptor (LTbR), for example, is critical for secondary lymphoid organ development, while signaling emanating from BAFFR is important for B-cell survival and maturation. Other TNFR superfamily members are critical for mediating inflammatory responses that may be initiated by pathogen sensing receptors of the TLR superfamily. TNFR superfamily members also play important roles in coordinating innate and adaptive immune responses. For example, two TNF receptors, TNFR1 and TNFR2, mediate the function of the proinflammatory cytokine TNF, and CD40R initiates a powerful B-cell proliferation and activation program upon binding of the ligand CD40L produced by T-cells. Though the distinction between immune development and immune response processes seems intuitive, a variety of observations point towards links between them. One focus of this review will be the signaling crosstalk between the molecular pathways that mediate immune responses and those that mediate immune developmental processes.
The NF-kB signaling system
The signaling system that controls the activity of nuclear factor kappaB (NF-kB) is responsive to virtually all TNFR superfamily members (Fig. 1 ). NF-kB activity consists of a family of dimeric transcription factors. Five related mammalian NF-kB proteins, namely RelA/p65, RelB, cRel/Rel, p50 and p52, can potentially form 15 different homo-or heterodimeric complexes [1] . The NF-kB proteins share an approximately 300 amino acid Rel homology region (RHR), which comprises domains for DNA binding, dimerization and www.elsevier.com/locate/cytogfr nuclear localization. NF-kB dimers bind to the promoters of a variety of genes via a sequence element termed the kappaB (kB) site, which exhibits a loose consensus 5 0 -GGRNN(WYYCC)-3 0 (where R: purine, N: any base, W: adenine or thymine and Y: pyrimidine). Sequence heterogeneity confers specificity to the promoters via differential utilization of specific NF-kB isoforms [1] .
Five proteins have also been identified that can inhibit NFkB activity. These include three inhibitors of NF-kB (IkBs), namely IkBa, -b and -e [2] [3] [4] , and two NF-kB precursor proteins, namely nfkb1 p105 and nfkb2 p100. Common to all five NF-kB inhibitors is the ankyrin repeat domain (ARD), which masks NF-kB DNA binding and nuclear translocation sequences [5] . NF-kB activation is achieved through stimulus-responsive proteolysis of the inhibitors. In fact, two mechanisms were originally proposed to account for the NF-kB activation [6] : (a) existence of latent activity bound to a separate inhibitor that releases NF-kB dimer during signaling, and (b) a precursor processing mechanism that generates active NF-kB dimer. The distinction between these two activation mechanisms, as discussed later, continues to be relevant to our current understanding of NF-kB signaling.
2. The canonical NF-kB signaling pathway 2.1. Latent NF-kB/RelA:p50 dimer bound to IkBs
The primary mediator of NF-kB function in most cell types is the RelA:p50 dimer. A C-terminal domain of RelA renders this heterodimer a potent transcriptional activator. The detergent deoxycholate was found to liberate kB DNA binding activity in the cytoplasmic extract prepared from the unstimulated cells, confirming the existence of latent NFkB/RelA:p50 that is bound to inhibitor(s) [7] , that were later identified as the three canonical or classical IkBs, IkBa, -b and -e. These inhibitors were also shown to retain cRelcontaining dimers and regulate their activation.
Activation and termination of canonical NF-kB response
NF-kB/RelA:p50 dimer activation through the classical or the canonical pathway, such as those transduced through TNFR1, involves signal responsive activation of IkappaB kinase (IKK). The IKK complex is composed of two catalytic subunits, IKK1/IKKa and IKK2/IKKb and several regulatory subunits, including the NF-kB essential modulator, NEMO. In general, the catalytic activity of IKK2 is required for canonical signaling [8, 9] . In response to a variety of inflammatory stimuli, the IKK complex phosphorylates IkBs at specific N-terminal serine residues (serine 32 and serine 36 for IkBa). Subsequent b-TrCPmediated ubiquitination of canonical IkBs promotes complete proteasomal degradation of the inhibitors to liberate bound NF-kB dimers [10] (Fig. 2A) . Interestingly, neither phosphorylation nor ubiquitination is sufficient to dissociate IkBs from the RelA:p50 dimer, and proteasomal degradation of IkBs is absolutely required for RelA:p50 nuclear translocation [11] . This mode of NF-kB activation in Fig. 1 . The TNF receptor superfamily and the NF-kB signaling system. Various members of the TNF receptor superfamily utilize the NF-kB signaling pathway to effect diverse physiological responses through a NF-kB-dependent gene expression program. The stimulus-specificity of the cellular response and the functional interaction of distinct stimuli via the NF-kB signaling system is the focus of this review. the canonical pathway is protein synthesis-independent. NFkB transcriptional activity is thought to be further modulated through phosphorylation and other post-transcriptional modifications of RelA [12] , but a clear understanding that relates RelA modification with its function is yet to emerge.
Interestingly, genes encoding IkBa and IkBe are also NFkB target genes. Therefore, NF-kB activation generates feedback inhibition within the pathway, whereby re-synthesized IkBs sequester nuclear NF-kB dimers and mediate nuclear export of the inhibited NF-kB dimers to ensure appropriate termination of the canonical NF-kB response.
NF-kB signaling dynamics and a mathematical model
As a result of IkB-mediated negative feedback, inflammatory stimuli result in NF-kB/RelA:p50 activity that shows complex temporal regulation. A detailed understanding of these biochemical events has allowed for the construction of a mathematical model that recapitulates the experimentally observed NF-kB activation dynamics during the TNF response [13, 14] . This mathematical model provided an in silico confirmation that the known biochemical mechanisms, such as stimulus-responsive degradation and re-synthesis of IkBs, its association/dissociation with the RelA:p50 dimer, nuclear import and export of free and IkB-bound RelA:p50 dimers, are sufficient to explain the observed NF-kB regulation in response to the canonical pathway activation (Fig. 2B) . By combining computation and biochemical analyses, the mathematical model was further refined to capture NF-kB signaling dynamics during TLR4 signaling [15, 16] .
3. Immune response regulation by the canonical NF-kB pathway
Canonical NF-kB activation during immune response
Innate immunity represents a first defense to pathogen infection, followed by adaptive immune responses. Pathogen associated molecular pattern (PAMP) recognition by epithelial or tissue resident hematopoietic cells induces expression of cytokines, which act as mediators of inflammation to recruit phagocytic cells for pathogen clearance. Interestingly, all known PAMPs induce IkB phosphorylation and RelA:p50 activation, and the resulting inflammatory cytokines are also potent inducers of the canonical NF-kB pathway. TNF, in particular, plays a prominent role in this positive autocrine and paracrine feedback. In addition, T-cell activation upon TCR signaling, B-cell activation upon BCR and CD40R engagement also involve NF-kB RelA:p50 activation. Therefore, the canonical NF-kB pathway appears to be intimately linked with the mounting and propagation of both innate and adaptive immune responses.
Mouse genetics indicate diverse canonical NF-kB functions in immunity
Mouse knockout studies have corroborated that NF-kB has an important role in immune responses. Initially, the embryonic lethality of rela À/À mice due to massive hepatocyte apoptosis [17] revealed a novel function of Signal responsive NF-kB/RelA:p50 dimers are bound to either canonical IkBs, IkBa, -b, -e, or to the noncanonical IkBd/asymmetric (p100) 2 . Inflammatory stimuli signal through the IKK2/IKKb to catalyze phosphorylation of canonical IkBs, directing them to proteasome-mediated degradation to release the bound RelA:p50 dimers into the nucleus. In contrast, the developmental cues signal through the IKK1/IKKa to mediate phosphorylation and degradation of IkBd, resulting in nuclear translocation of the bound RelA:p50 dimers. In contrast, auto-inhibited dimeric complexes of p100 and other Rel proteins are signal unresponsive. (B) A mathematical model that describes inflammatory IKK2 mediated degradation of IkBa, -b and -e and developmental IKK1 mediated degradation of IkBd to release the bound NF-kB/RelA:p50 dimer into the nucleus. Once in the nucleus, NF-kB/ RelA:p50 dimer activates transcription of many genes that include NF-kB inhibitors, IkBa, IkBe and IkBd, thereby orchestrating an example of feedback inhibition loop. The yellow box depicts the scope of the current version of a mathematical model [35] that is capable of recapitulating NF-kB/RelA:p50 dimer activation in response to TNFR and LTbR signaling. The model contains 98 differential equations representing interactions between RelA;p50, IkBa, IkBb, IkBe, IkBd, IKK1 and IKK2, synthesis and degradation of IkB proteins and mRNA, nuclear-cytoplasmic transport of these components and their complexes.
RelA:p50 as an anti-apoptotic regulator but presented obstacles for genetically assessing RelA's function in the immune system. When the lethality was rescued upon combined inactivation of the gene encoding TNFR1, the resulting rela À/À tnfr1 À/À mice showed an increased susceptibility to bacterial infection and succumbed to neonatal death [18] . Radiation chimeras that were reconstituted with RelA/TNFR1 deficient hematopoietic cells also indicated a role for RelA in mounting immune responses.
Deficiency in NF-kB component p50 resulted in reduced levels of serum immunoglobulins in nfkb1 À/À mice, indicating a role for the canonical pathway in humoral responses. In addition, B-cells derived from nfkb1 [19] [20] [21] . Similar studies have also established an important role for canonical NF-kB dimers in thymocyte maturation [22] , T-cell proliferation, survival and in vivo function [23] , and in dendritic cell development [24] . In sum, these genetic analyses have established a role for the canonical NF-kB pathway in innate and adaptive immune compartments, in both cell activation and development. Further animal studies are warranted to probe the functional specificity of individual NF-kB subunits in immune cells during actual immune responses to pathogens.
NF-kB-dependent gene expression during immune response via the canonical pathway
The importance of the NF-kB system in immunity is underscored by an impressive list of genes that have been reported to contain functional kB-elements (www.nfkB.org). These genes include a large number of inflammatory mediators, such as cytokines, chemokines, their receptors and membrane bound proteases, as well as genes that can counteract apoptosis. More recent genetic studies have established that the majority of TNF-induced gene activation events in MEF do indeed require NF-kB, and that different target genes have differential requirements for canonical NF-kB dimers, such as the RelA:p50 heterodimer vs. RelA:RelA homodimers, or cRel-containing dimers [25] . Furthermore, using a non-degradable form of IkB as a transgenic repressor of NF-kB function, large numbers of genes were shown to be expressed in an NF-kB-dependent manner in a variety of transformed cell-lines.
However, in healthy, primary immune cells, it remains unclear how many genes are critically regulated by NF-kB, which dimers are involved and which of these target genes are responsible for physiological phenotypes in knockout mice. Interestingly, a recent study revealed that in dendritic cells, TLR4 induced expression of inflammatory or T-cell stimulatory genes require distinct RelA or cRel subunits [26] , suggesting that there is a regulatory code for canonical NF-kB dimers that remains to be elucidated. Given the abundance of NF-kB (more than 100,000 molecules per cell), it may not be surprising that genome-wide chromatin immunoprecipitation (ChIP) analysis revealed a large number of unexpected binding sites of unknown functional relevance [27, 28] . Therefore, such chromatin location studies must be coupled to functional analysis using genetic perturbations (knockouts and knockin mutants) to elucidate the transcriptional regulatory code of NF-kB.
4.
Immune organ development and the NF-kB/RelA:p50 dimer
Secondary lymphoid organ development via the LTbR
Secondary lymph nodes provide a microenvironment for antigen recognition and lymphocyte maturation during an adaptive immune response. Lymph nodes are located throughout the body to monitor the draining fluids and migrating lymphocytes for pathological changes [29, 30] . The ltbr À/À mice demonstrated that lymphotoxin-b receptor (LTbR) signaling critically regulates lymph node formation [31, 32] . During early embryogenesis, membrane bound LTa 1 b 2 on the hematopoietically derived lymph tissue inducer (LTi) cells signal through LTbR present on the stromal organizer cells to initiate lymph node development. LTbR engagement results in the production of organogenic chemokines, namely SLC (CCL21), BLC (CXCL13) and ELC (CCL19), whose secretion allow further influx of LTi cells, and cell adhesion molecules, such as ICAM-1 and VCAM-1, whose expression on stromal cells allows for adherence of LTi cells through cell-surface integrins. Subsequent clustering between LTi cells and stromal cells leads to the formation of secondary lymph nodes in the specific areas of the lymph node anlagen. Additionally, signaling through LTbR was shown to regulate spleen architecture, T-/B-cell segregation, germinal center formation and maintenance of lymph node microarchitecture in adult mice [33] .
Requirement of RelA and p50 in the lymph node development
Beside its role in immune activation, the NF-kB RelA:p50 dimer has also been implicated in the immune development. Mice that lack RelA (combined with TNFR1 deficiency) revealed an early organogenic defect resulting in a complete lack of secondary lymph nodes in newborn mice. Analysis with radiation chimeras suggested a requirement for RelA within the non-hematopoietic stromal cells for the development of secondary lymphoid organs [19] . Similarly, p50-deficient mice exhibited defects in lymphoid tissues with a loss of inguinal lymph nodes [30] . A requirement of the RelA:p50 dimer in stromal cells for activating VCAM-1 or ICAM-1 gene expression during LTbR signaling [30, 34] was proposed to be responsible for these lymph node phenotypes.
Mapping the RelA:p50 dimer activation pathway downstream of LTbR
An LTbR agonist antibody that functionally complements the genetic deletion of LT-ligands in mice [32] was used in a cell culture system to reveal RelA:p50 activation downstream of LTbR and for further analyzing the underlying activation mechanism [35] . In contrast to TNFR, LTbR stimulation may not induce IKK2-complex activity or the degradation of the three canonical IkB proteins, IkBa, -b and -e. Indeed, knockout MEF that lack all three canonical IkBs were shown to be defective in RelA:p50 activation in response to TNFR but not LTbR stimulation. As a result, the existence of an additional NF-kB inhibitor was proposed that regulates RelA:p50 activity during LTbR signaling.
Biochemical purification identified nfkb2/p100 as an additional RelA:p50-interacting protein. The precursor for the NF-kB protein p52, p100, possesses seven ankyrin repeats in the C-terminal inhibitory domain that was thought to keep it functionally inert. However, analyses of both recombinant and cellular p100 suggested that p100 can form a homodimer through its N-terminal RHR, and utilizes the ARD of one polypeptide in an autoinhibitory conformation but allows the ARD of the second polypeptide to associate with additional NF-kB dimers in trans (Fig. 2A) . Such cytoplasmic (p100) 2 -inhibited complexes could be disrupted with deoxycholate, liberating bound RelA:p50 DNA binding activity. As such, the ''second ARD'' of the asymmetric (p100) 2 dimer was proposed to function as a fourth IkB, termed IkBd [35] .
Several developmental stimuli (e.g. LTa 1 b 2 , BAFF, RANKL, CD40L) have been described to activate NF-kBinducing kinase (NIK) and IKK1, and trigger processing of p100 to p52 and nuclear accumulation of RelB:p52 NF-kB dimers [36] [37] [38] . This was termed the ''non-canonical'' or the ''alternative'' NF-kB pathway. The recent work [35] revealed that stimulus-induced processing of p100 to p52 in the context of a multimeric (p100) 2 complex amounts to degradation of IkBd resulting in the release of bound RelA:p50 into the nucleus. The remaining p100:p52 dimer is self-inhibited and retained in the cytoplasm. Consistent to this proposal, nik À/À MEF displayed defects in NF-kB/RelA dependent gene expression during LTbR signaling [39] . Similarly, signals transduced through CD40R and BAFFR that control B-cell maturation were also shown to utilize the NIK pathway for RelA activation [40] . The new model indicates a signaling axis that connects NIK and IKK1 with RelA:p50 activation during developmental signaling via stimulus-induced IkBd degradation.
In sum, all NF-kB-inducing pathways activate RelA:p50 dimers from a latent cytoplasmic pool. Whereas the immune activation signals utilize the canonical NF-kB pathway and the three canonical IkB proteins IkBa, -b, -e, immune developmental signals utilize the non-canonical pathways and IkBd. NF-kB activation in response to developmental signals is weaker and delayed compared to inflammatory signals. The use of the smaller IkBd bound pool, as opposed to the larger canonical IkB-bound pool, controls the amplitude of the RelA:p50 response during LTbR signaling. As differential thresholds of NF-kB activity may determine target gene expression, such amplitude modulation may therefore enable the expression of cell survival and cell adhesion molecules without generating an inflammatory response during developmental processes.
Interconnected pathways for inflammatory and developmental signaling

A ''four IkB'' containing mathematical model
Unlike the three canonical IkBs, IkBd is not degraded in response to IKK2 mediated inflammatory signals, but its expression is induced due to NF-kB-dependent transcriptional activation of nfkb2/p100 [41] . To further address the relationship between canonical and non-canonical signaling, a set of ordinary differential equations that describe synthesis, degradation and molecular interactions of p100 was included into a mathematical model that already accounted for NF-kB activation dynamics in inflammatory settings [13] . The resulting model [35] included 98 biochemical reactions, which were parameterized based on biochemical measurements and parameter fitting algorithms. Simulation runs using this in silico model recapitulated IKK2-mediated degradation of classical IkBs during TNFR1 signaling as well as IKK1-mediated proteolysis of p100/IkBd during LTbR signaling to predict NF-kB/RelA:p50 dimer activation dynamics in response to canonical or the non-canonical signals (Fig. 2B ).
Crosstalk between the signaling mediated through TNFR1and LTbR
Remarkably, simulations with the four IkB-containing mathematical model predicted that even a transient inflammatory exposure would have a lasting effect on the IkB homeostasis, such that the TNF-primed cells would display hyperactivation of RelA:p50 dimer during subsequent LTbR signaling, as compared to naïve cells [35] . Indeed, biochemical experiments revealed an altered distribution of canonical and non-canonical IkB proteins, with an increased fraction of RelA:p50 dimer bound to IkBd in TNF-primed cells. In TNF-primed cells, non-canonical signaling mediated through LTbR not only resulted in increased NF-kB activity, but also had qualitative effects on gene expression [35] . Prominent RelA target genes, such as ikba and tnf, that are not normally induced during LTbR signaling, were shown to be activated by the non-canonical pathway in TNF-primed MEF. Therefore, inflammatory signaling appears to amplify developmental responses of NF-kB/RelA:p50 via a crosstalk mechanism that controls the cellular homeostasis of canonical and non-canonical IkB proteins.
Implications of the signaling crosstalk in physiology
Within their physiological context, cells receive and process signals from a variety of extracellular cues. Therefore, the signaling crosstalk that modulates the amplitude of the NF-kB response during developmental processes may have profound physiological significance. Indeed, tnfr1 À/À mice revealed developmental defects with a lack of Peyer's patches and disrupted marginal zone formation [42] . In vitro generation of fibroblast reticular cells from lymph node tissue was shown to require both TNFR and LTbR signaling [43] , while in utero treatment of decoy receptors that abrogated TNFR or LTbR signaling or both revealed a co-operation between TNF/LT pathways that underlie lymph node biogenesis [32] . Also, signaling through both LTbR and TNFR was shown to be required for dendritic cell development and expansion [44] . Utilization of TNFR by LTa 3 homotrimer ligand was thought to constitute a functional connection between the TNF and LT axes. The above-described model [35] , instead, proposes a cell-autonomous signaling crosstalk mechanism via IkBd to provide an alternative explanation for the requirement of inflammatory signaling in developmental pathways. In this proposal, inflammatory signaling regulates the strength of the non-canonical NF-kB signaling pathway and thereby the cellular responsiveness to developmental cues (Fig. 3A) .
One might speculate that in other cases where such developmental cues may be persistently present or tonic, the canonical signaling pathway (initiated by transient inflammatory stimuli) may increase the cellular responsiveness to these tonic signals. Interestingly, it was proposed that inflammatory signaling co-operates with the non-canonical signaling mediated through receptor activator of NF-kB ligand (RANK) to accelerate differentiation of the precursors into mature osteoclasts within bone marrow and in peripheral tissues [45] . Indeed, TNFa signaling, through TNFR1, enhanced osteoclast formation in vitro from the precursors that were pre-treated with RANKL [46, 47] . The significance of such crosstalk mechanisms in bone resorption and homeostasis and in rheumatoid arthritis remains to be fully explored. Furthermore, how B-cell survival and proliferation program, mostly guided by the chronic signals mediated through BAFFR (and CD40R), is altered upon exposure to the transient inflammatory stimuli also remains to be investigated to fully understand the implications of the proposed signaling crosstalk between canonical and noncanonical signal transduction pathways.
Implication of the signaling crosstalk in disease
The homeostatically controlled distribution of canonical and non-canonical IkB proteins is also subject to diseaseassociated perturbations; such altered IkB homeostasis may be the underlying cause for pathological misregulation of NF-kB.
Chronically elevated nuclear NF-kB/RelA:p50 activity has long been associated with many different types of cancer, where it contributes to survival signaling, chemoresistance, proliferation and metastasis [48] . Indeed, an elevated constitutive IKK2 activity has been observed in many different cancer cell-lines. With the newly appreciated role of IkBd/(p100) 2 as a fourth IkB that is not degraded in response to IKK2 signals, one might expect that IkBd functions as an important brake to elevated canonical signaling (Fig. 3B) . Indeed, in the absence of canonical IkB proteins, IkBd limits NF-kB activity in MEF by sequestering an increased amount of RelA:p50 dimer in the cytoplasm [35] . Similarly, samples derived from primary breast tumors and derived cell-lines revealed an elevated level of p100 protein that sequesters NF-kB dimers in the cytoplasm [49] .
Further computational simulations predicted that such altered IkB homeostasis would also render cells hyperresponsive towards developmental stimuli, in that the degradation of IkBd upon LTbR signaling resulted in a heightened RelA:p50 dimer activation [35] . Experimental analyses demonstrated that LTbR stimulation in ikba
MEF induced significantly more RelA:p50, as well as expression of inflammatory cytokines not normally induced in wild type cells by the same stimulus. Therefore, we suggest that disease-associated perturbations of the NF-kB system, which alter the strength of the non-canonical pathway, may turn the usually subtle cellular responses to weak, possibly tonic developmental signals into gene expression programs that contribute to pathologies (Fig. 3C) .
There are some indications in the literature that altered responsiveness of disease-associated cells renders normally benign developmental signals to have significant pathological roles. For example, an inflammatory skin condition caused by keratinocyte-specific deletion of IkBa could be partially rescued not only by deletion of tnf or tnfr1, but also lta, with only compound deficiency of tnf, lta and ltb completely rescuing this skin phenotype [50] . Furthermore, a significant fraction of the malignant Reed Sternberg cells in Hodgkin lymphoma have been shown to harbor functionally defective ikba gene [51] . But more recently is was shown that signaling by BAFF is critical not only for promoting survival of these diseased cells, but also their growth and proliferation [52] . Finally, it is remarkable that components of the non-canonical pathway, such as LTbR, NIK, or NFkB2, are more often found to be mutated or misregulated in multiple myeloma than components of the canonical NF-kB pathway. Inhibition of this hyperactivated non-canonical pathway indeed led to growth arrest and cell death in vitro [53, 54] .
Inflammation has been identified as a tumor promoter, and the molecular link between them was identified as deregulated IKK2 and NF-kB activity [55] . However, in cell culture, increased p100/IkBd protein levels due to chronic inflammation severely attenuates the NF-kB response [35] (data not shown, Shih and Hoffmann, UCSD). Based on these observations, we propose that the non-canonical signaling pathway plays a critical role in controlling aberrant NF-kB activity associated with cancer cells (Fig. 3D) . Noncanonical signaling could be the result of tonic developmental paracrine signals in situ, or an autocrine signaling loop acquired by the cancer cell. Therefore, we suggest that tonic developmental cytokines, could provide an opportunity for therapeutic intervention.
6. Towards an understanding of the multi-dimer NF-kB signaling system 6.1. Non-canonical activation of NF-kB/RelB DNA binding activity Non-canonical signaling results not only in RelA:p50 activation, but there is significant literature on the activation of the RelB:p52 dimer, which may be slower and more persistent. LTbR stimulation was shown to induce nuclear accumulation of RelB:p52 via the NIK/IKK1 mediated phosphorylation and processing of de novo synthesized, rather than pre-existing p100 protein into p52 [37, 56, 57] . Indeed, a first phase of RelA activity was proposed to induce p100 synthesis to amplify RelB:p52 dimer activation [34, 58] , but recent evidence indicates that RelA-responsive expression of RelB is more important in this regard [59] . Signaling through multiple other TNF receptor superfamily members, such as BAFFR, CD40R, BCMA, TAC1 or RANK, was also reported to activate the RelB:p52 dimer via the non-canonical pathway.
Indeed, genetic analysis indicated that RelB plays an essential role in lymph node development, especially in maintaining lymph node architecture in adult mice [60, 61] . Important lymphoid chemokine genes, such as BLC and SLC, were shown to be RelB target genes [59, 62] via a proposed variant kB site that recruits RelB-but not RelAcontaining dimers upon LTbR stimulation [63] . Homozygous knockin mice expressing a non-activatable IKK1 variant (ikk1 AA/AA ) show impaired lymphoid organogenesis [37] due to stromal cell defects [63] . These studies established that the non-canonical pathway plays a critical role in development of lymphoid tissues. However, genome-wide analysis to identify RelB target genes downstream of LTbR is wanting and bears the promise to define the promoter code for RelA and RelB containing NF-kB dimers.
Disparate lymph node phenotype in various NF-kB knockouts
The straightforward model that describes canonical signaling as controlling inflammation and non-canonical signaling as controlling secondary lymphoid tissue development is, however, not well supported by mouse knockout studies. For example, nfkb2 À/À mice, which are deficient in the primary regulators of non-canonical NF-kB signaling p100/p52, display defects only in the inguinal lymph node formation with all other nodes present at wild type frequencies [30] . It was proposed that the RelB:p50 dimer may be responsible for the incomplete penetrance of phenotype in nfkb2 À/À mice. Indeed, nfkb1
double knockout mice displayed complete lack of lymph nodes, thus phenocopying LTbR deficient mice [30] . Interestingly, nfkb1 À/À mice were also shown to have inguinal lymph node defects and derived MEF showed attenuated RelB activation in response to LTbR stimulation [30] . As described earlier, rela À/À mice also exhibited an early organogenic defect with complete absence of lymph nodes in newborn mice [19] , and RelB:p52 dimer activation by LTbR signaling was shown to be defective in rela À/À MEF [59] . As opposed to the commonly held view of distinct canonical and non-canonical signaling axes, these studies indicated the potential involvement of multiple cross-regulatory mechanisms, whose details may best be presented and characterized within network description of the NF-kB signaling system.
A multi-NF-kB dimer signaling system
We have recently explored the functional interconnectedness of these two pathways by systematically characterizing the mechanisms that control the generation of each of the relevant NF-kB dimers and thereby determine their availability for stimulus-responsive activation [59] . The interdependencies between the components of the NF-kB signaling system could be represented using a wiring diagram (Fig. 4) . Here, the preferred biochemical reactions have been indicated with a solid line, lesser reactions with a dashed line. Feedback reactions are denoted with a green line, constitutive and inducible processes with black and red lines, respectively.
The model shows that inflammatory signals activate RelA:p50 dimer through IKK2 mediated IkB degradation, while IkBd/(p100) 2 -inhibited RelA:p50 and RelB:p50 complexes are released into the nucleus upon IKK1 mediated developmental signaling. Furthermore, p52 is co-translationally generated from p100 in response to IKK1 signaling [56] and dimerizes with RelB and RelA to appear as RelB:p52 and RelA:p52 DNA binding complexes. The RelA:p50 dimer controls RelB synthesis and thus modulates stimulus-responsive activation of the RelB dimers via the non-canonical pathway. On the other hand, feedback inhibition mediated by the re-synthesized IkBs is capable of terminating RelA responses. In addition, it was shown that the RelB-containing dimers could upregulate NFkB2 and RelB mRNA synthesis [59] , forming a positive feedback loop in the pathway. Finally, p50 and p52 compete with each other for binding to a limited pool of RelA and RelB proteins. Constitutive p105 processing generates p50 in the resting cell. In contrast, p100 is stabilized by RelB (A. Fusco and G. Ghosh, UCSD) but its processing to p52 is responsive to developmental stimuli such as LT.
Perturbations in the NF-kB signaling system via gene knockouts
Studies of single and compound NF-kB gene deletions resulted in unexpected mouse phenotypes and perturbed RelB:p52 dimer activation by LTbR signaling [30, 59] . Analysis of the proposed model as depicted in the systemwiring diagram in Fig. 4 not only assists in understanding the molecular basis of these knockout phenotypes but also confirms the existence of multiple cross-regulatory mechanisms as emergent systems properties.
First, the lack of RelA activity not only resulted in the complete absence of NF-kB activity during inflammatory signaling, but also abrogated the non-canonical pathway. Fig. 4 . A wiring diagram [59] to depict functional relationships between various components within the NF-kB signaling system. NF-kB monomers are shown in black, cytoplasmic dimers in blue and nuclear dimers in red. Constitutive processes are shown in black lines, regulated processes in red and feedback processes in green. Preferred biochemical reactions are shown in solid lines, while lesser reactions in dashed line. The wiring accounts for the generation and activation of four NF-kB dimers that are detected in response to LTbR signaling, namely RelA:p50, RelA:p52, RelB:p50 and RelB:p52 dimers. The NF-kB signaling system receives signals from both inflammatory and developmental cues through IKK2 and IKK1 kinases, respectively, to activate distinct NF-kB dimers during inflammation or during development. See the text for a detailed description.
Two distinct mechanisms emerge when analyzing the proposed NF-kB signaling system model to account for such defective RelB activation. First, RelA deficiency reduces RelB (and also p100) mRNA synthesis. Second, excess p50 monomer (resulting from the lack of RelA) competes with p52 for RelB binding and thus interferes with p52 generation and RelB:p52 dimer formation. Indeed, in cell culture, RelA-deficiency was shown to result in a reduced level of RelB mRNA and protein, and also p52 generation by LTbR signaling was shown to be abrogated in rela À/À MEF but was rescued in rela À/À nfkb1 À/À MEF [59] . It has been suggested that RelB binding to p100 inhibits its stimulus-responsive processing (A. Fusco and G. Ghosh, UCSD), whereas RelA-bound p100 is subjected to constitutive processing [59] . The wiring diagram indicates that in the absence of its preferred interaction partner p50, RelA would compete with RelB to bind p100. RelA binding would then allow for an increased accumulation of p52 through constitutive p100 processing. Indeed, elevated p100 processing into p52 was observed in nfkb1 À/À MEF [59] that resulted in functional compensation at the level of kB-DNA binding activity and gene expression in response to TNF stimulation [25] . However, elevated processing also depletes the cellular pool of p100 that can be inducibly processed into p52 during non-canonical signaling. As such, functional compensation in inflammatory signaling impairs the system's responsiveness to developmental signals. Therefore, the system wiring diagram illustrates an explanation for the observed NF-kB activation defect in nfkb1 À/À MEF that may impair lymph node development in nfkb1 À/À mice [30] . In concordance to the competition hypothesis, elevated constitutive p100 processing was reduced to normal levels in rela
À/À MEF [59] . Similarly, the wiring diagram illustrates that in nfkb2 À/À MEF, the majority of the RelB protein is available to bind p50. As RelB:p50 is not subject to efficient inhibition by IkB proteins, it appears as a constitutive DNA binding activity in the nucleus. We postulate that the transcriptional activity of the constitutive RelB:p50 dimer [59] partly masks a phenotype that is otherwise expected in nfkb2 À/À mice [30] . In sum, genetic and biochemical analyses indicated that lymph node development and its maintenance requires both components of the canonical (rela and nfkb1) and the noncanonical pathway (relb and nfkb2). Understanding LTbR signaling requires integration of both pathways into a single NF-kB signaling system, which describes the generation of a number of NF-kB dimers and their interactions with IkB proteins. Regulation of the homeostasis of dimer availability emerged as an important theme in understanding NF-kB activation during LTbR signaling. Hence, the system wiring diagram not only emphasized the functional interdependence of the canonical and the non-canonical pathways, but the functional relationships between homeostatic mechanisms that are responsible for NF-kB dimer generation and the stimulus-induced, dynamic mechanisms that control dimer activation.
Concluding remarks
As mouse genetic studies of signaling proteins have yielded surprising phenotypes and thus revealed unexpected functional interdependencies and redundancies, we are forced to confront the interconnectedness of a signaling network that breaks the simplifying assumptions of linear signaling pathways. With a large number of TNFR superfamily members functionally interacting with a complex NF-kB signaling system consisting of 15 possible dimers, a systems biology approach may be called for in addressing questions of signaling specificity and crosstalk. Within this context, mathematical modeling of the signaling system allows for quantitative predictions and motivates a quantitative biochemical and biophysical analysis of protein interactions and kinetic reactions.
Given the importance of the NF-kB signaling system in physiology and disease, further studies that address the specificity of RelA and RelB-mediated gene expression programs, signaling crosstalk in both physiological and pathological contexts, and alternate homeostatic signaling states during cell differentiation, and in cancer-associated perturbations will be of great interest. Quantitative computational modeling may be a useful tool to complement systematic experimental studies, and may lead to novel therapeutic strategies that minimize non-specific or offtarget side effects.
